摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-salicylaldehyde | 163117-72-4

中文名称
——
中文别名
——
英文名称
3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-salicylaldehyde
英文别名
3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methoxy-salicylaldehyde;2-hydroxy-3-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)methoxy]benzaldehyde
3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-salicylaldehyde化学式
CAS
163117-72-4
化学式
C22H26O3
mdl
——
分子量
338.447
InChiKey
RVNZPMXPPGYLAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    摘要:
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00047-x
  • 作为产物:
    描述:
    2,3-二羟基苯甲醛6-(氯甲基)-1,1,4,4-四甲基-1,2,3,4-四氢萘 在 sodium hydride 、 二甲基亚砜 作用下, 以 二甲基亚砜 为溶剂, 反应 1.0h, 以44%的产率得到3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methoxy-salicylaldehyde
    参考文献:
    名称:
    Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    摘要:
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00047-x
点击查看最新优质反应信息

文献信息

  • Biaryl phospholipase A.sub.2 inhibitors
    申请人:Bristol-Myers Squibb
    公开号:US05391817A1
    公开(公告)日:1995-02-21
    Certain novel biaryl compounds are effective phospholipase A.sub.2 (PLA.sub.2) inhibitors.
    某些新型联苯化合物是有效的磷脂酶A.sub.2(PLA.sub.2)抑制剂。
  • Biaryl phospholipase A2 inhibitors
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP0664282A1
    公开(公告)日:1995-07-26
    Biaryl compounds, effective phospholipase A₂ (PLA₂) inhibitors of Formulas I and II: wherein: Y= COOH, CH₂CO₂H, H, F, Cl, Br, I, COOR', CH₂CO₂R', CONH₂, COR'', CHO, CH₂OH, CH₂OR'', OH, OR'', CF₃, C₁₋₆ alkyl, C₁₋₆ alkenyl, C₁₋₆ haloalkyl, NO₂, P(O) (OH)₂, SO₂H, or SO₃H; Z= H, F, Cl, Br, I, CONH₂, COR'', CHO, CH₂OH, CH₂OR'', OH, OR'', CF₃, C₁₋₆ alkyl, C₁₋₆ alkenyl, C₁₋₆ haloalkyl, NO₂, P(O)(OH)₂, SO₂H, or SO₃H; X= (CH₂)n, n = 0, 1, or 2; or a cis or trans CH=CH; R= substituted or unsubstituted alkyl, aryl, arylalkyl, alkyloxy, arylalkyloxy, alkenyl, or arylalkenyl groups with the proviso that R must have 8 or more carbons; R'= H, C₁₋₆ alkyl, C(R¹)₂OC(O)R², CH₂CH₂NR³R⁴, CH₂CH₂CH₂NR³R⁴, or other groups yielding physiologically hydrolyzable esters; R''= C₁₋₆ alkyl; R¹= H, CH₃, C₂H₅, CH₂CH₂CH₃; R₂= C₆₋₁₂ aryl, C₁₋₇ linear, branched or cyclic alkyl, or C₁₋₇ linear branched or cyclic alkoxy; R³= R⁴, or, it may be linked with R⁴, to form a C₃-C₆ cycloalkyl or a -CH₂CH₂OCH₂CH₂- group; and R⁴= C₁₋₃ alkyl; or salts thereof.
    式 I 和 II 的有效磷脂酶 A₂(PLA₂)抑制剂--联苯化合物: 其中 Y= COOH、CH₂CO₂H、H、F、Cl、Br、I、COOR'、CH₂CO₂R'、CONH₂、COR''、CHO、CH₂OH、CH₂OR''、OH、OR''、CF₃、C₁₋₆ 烷基、C₁₋₆ 烯基、C₁₋₆ 卤代烷基、NO₂、P(O) (OH)₂、SO₂H 或 SO₃H; Z= H、F、Cl、Br、I、CONH₂、COR''、CHO、CH₂OH、CH₂OR''、OH、OR''、CF₃、C₁₋₆ 烷基、C₁₋₆ 烯基、C₁₋₆ 卤代烷基、NO₂、P(O)(OH)₂、SO₂H 或 SO₃H; X= (CH₂)n,n = 0、1 或 2;或顺式或反式 CH=CH; R= 取代或未取代的烷基、芳基、芳烷基、烷氧基、芳烷氧基、烯基或芳烯基,但 R 必须具有 8 个或 8 个以上碳原子; R'=H、C₁₋₆烷基、C(R¹)₂OC(O)R²、CH₂CH₂NR³R⁴、CH₂CH₂CH₂NR³R⁴或其他可产生生理性水解酯的基团; R''= C₁₋₆ 烷基; R¹= h、ch₃、c₂h₅、ch₂ch₂ch₃; R₂= C₆₋₁₂ 芳基,C₁₋₇ 直链、支链或环状烷基,或 C₁₋₇ 直链、支链或环状烷氧基; R³= R⁴,或可与 R⁴ 连接,形成 C₃-C₆ 环烷基或 -CH₂CH₂OCH₂CH₂- 基团;以及 R⁴= C₁₋₃ 烷基;或其盐。
  • US5391817A
    申请人:——
    公开号:US5391817A
    公开(公告)日:1995-02-21
  • Biaryl diacid inhibitors of human s-PLA 2 with anti-inflammatory activity
    作者:Dane M. Springer、Bing-Yu Luh、Joanne J. Bronson、Katharine E. McElhone、Muzammil M. Mansuri、Kurt R. Gregor、David O. Nettleton、Paul L. Stanley、Kenneth M. Tramposch
    DOI:10.1016/s0968-0896(00)00047-x
    日期:2000.5
    Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A(2) (HP-PLA(2)). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biaryl-propanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA(2). Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation. (C) 2000 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 顺式-4-(4-氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 顺式-4-(3,4-二氯苯基)-1,2,3,4-四氢N-叔丁氧羰基-1-萘胺 顺式-1-苯甲酰氧基-2-二甲基氨基-1,2,3,4-四氢萘 顺式-1,2,3,4-四氢-5-环氧丙氧基-2,3-萘二醇 顺式-(1S,4S)-N-甲基-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺扁桃酸盐 顺-5,6,7,8-四氢-6,7-二羟基-1-萘酚 顺-(+)-5-甲氧基-1-甲基-2-(二正丙基氨基)萘满马来酸 阿洛米酮 阿戈美拉汀杂质醇(A) 阿戈美拉汀杂质 钠2-羟基-7-甲氧基-1,2,3,4-四氢-2-萘磺酸酯 金钟醇 邻烯丙基苯基溴化镁 那高利特盐酸盐 那高利特 过氧化,1,1-二甲基乙基1,2,3,4-四氢-1-萘基 贝多拉君 螺<4.7>十二烷 蔡醇酮 萘磺酸,二癸基-1,2,3,4-四氢- 萘并[2,3-d]咪唑,2-乙基-5,6,7,8-四氢-(6CI) 萘亚胺 苯甲酸-(5,6,7,8-四氢-[2]萘基酯) 苯甲丁氮酮 苯甲丁氮酮 苯甲丁氮酮 苯并烯氟菌唑 舍曲林二甲基杂质盐酸盐 舍曲林EP杂质B 舍曲林 羟甲基四氢萘酚 美曲唑啉 罗替戈汀硫酸盐 罗替戈汀杂质18 罗替戈汀中间体 罗替戈汀中间体 罗替戈汀 罗替戈汀 纳多洛尔杂质 米贝地尔(二盐酸盐) 盐酸舍曲林 盐酸舍曲林 盐酸罗替戈汀 盐酸左布诺洛尔 盐酸四氢唑林 甲基缩合物 甲基6-[1-(3,5,5,8,8-五甲基-5,6,7,8-四氢-2-萘基)环丙基]烟酸酯 甲基-(2-吡咯烷-1-基甲基-1,2,3,4-四氢-萘-2-基)-胺 环丙烯并[a]茚,1-溴-1-氟-1,1a,6,6a-四氢-